| 000 | 01769 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513103842.0 | ||
| 264 | 0 | _c19970211 | |
| 008 | 199702s 0 0 eng d | ||
| 022 | _a1010-7940 | ||
| 024 | 7 |
_a10.1016/s1010-7940(96)80339-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMartin, W | |
| 245 | 0 | 0 |
_aRespiratory dysfunction and white cell activation following cardiopulmonary bypass: comparison of membrane and bubble oxygenators. _h[electronic resource] |
| 260 |
_bEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery _c1996 |
||
| 300 |
_a774-83 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aBlood Gas Analysis |
| 650 | 0 | 4 |
_aCardiopulmonary Bypass _xadverse effects |
| 650 | 0 | 4 |
_aComplement Activation _ximmunology |
| 650 | 0 | 4 |
_aComplement C3a _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukocyte Elastase _xblood |
| 650 | 0 | 4 |
_aMalondialdehyde _xblood |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOxygenators _xadverse effects |
| 650 | 0 | 4 |
_aRespiration Disorders _xblood |
| 650 | 0 | 4 |
_aThromboxane B2 _xblood |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_avon Willebrand Factor _xmetabolism |
| 700 | 1 | _aCarter, R | |
| 700 | 1 | _aTweddel, A | |
| 700 | 1 | _aBelch, J | |
| 700 | 1 | _ael-Fiky, M | |
| 700 | 1 | _aMcQuiston, A M | |
| 700 | 1 | _aMcLaren, M | |
| 700 | 1 | _aWheatley, D J | |
| 773 | 0 |
_tEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery _gvol. 10 _gno. 9 _gp. 774-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1010-7940(96)80339-3 _zAvailable from publisher's website |
| 999 |
_c8897830 _d8897830 |
||